Dépêchezvous frappé stimuler esophageal cancer markers Correction Boueux Cerise
Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics | Nature Communications
Membrane markers of esophageal cancer stem cells. | Download Table
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect
Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions | Cancer Cell International | Full Text
IJMS | Free Full-Text | Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers
Genomics, Molecular Markers, and Targeted Therapies in Esophageal Cancer | Thoracic Key
Frontiers | Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment
Study Points to Genetic Subtypes of Esophageal Cancer - NCI
Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging | SpringerLink
Tumor Biomarkers
Cell markers and signaling pathways of human lung and esophageal cancer... | Download Table
Immunohistochemical markers in esophageal carcinoma | Download Scientific Diagram
Comparison of different tumor markers in patients with esophageal... | Download Scientific Diagram
Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers
Changes in serum tumor marker levels relative to those under... | Download Scientific Diagram
Cancers | Free Full-Text | The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers
Esophageal Cancer: Practice Essentials, Background, Anatomy
Clinical Utility of Tumor Markers
Young-onset esophageal adenocarcinoma: Results from a population-based study - Mayo Clinic
Cells | Free Full-Text | Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer
Fat density is a novel prognostic marker in patients with esophageal cancer - Clinical Nutrition ESPEN
Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk? - eBioMedicine
Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment | Nature Communications
Frontiers | Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma